Acquired absence of genital organ(s). Acquired absence of genital organ(s)
Conditions
Interventions
Intervention 1: Intervention group: Patients will receive a single dose of 500 mg metronidazole ampoule the night before surgery, and on the day of surgery, they will also receive 2 grams of intraveno
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: ge over 18 years Women who are candidates for abdominal hysterectomy and ovarian cystectomy Consent to participate in the study
Exclusion criteria
Exclusion criteria: Sensitivity to metronidazole Emergency hysterectomy Hysterectomy after cesarean section or vaginal delivery or in the postpartum period Receiving broad-spectrum antibiotics before surgery Vaginitis or cervicitis Unwillingness to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Documented postoperative infection or patient-reported symptoms, including fever, unusual pain, purulent discharge from the incision site or vagina, indicating infection. Timepoint: Postoperative visits, including the third day visit and the 2-6 week post-operative visit. Method of measurement: By clinical examination by a gynecologist or symptoms reported by the patient, including (fever, abnormal pain, purulent discharge from the incision site or vagina) indicating infection. | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative complications: Blood transfusion, intestinal injury, urinary tract injury, estimated mean blood loss. Timepoint: During the operation. Method of measurement: Recording information during the operation.;Postoperative complications: Fever, purulent discharge from the vagina or incision site, and abnormal abdominal and pelvic pain, burning sensation during urination, wound redness, erythema, drainage, vaginal discharge, vaginal cuff cellulitis or vaginitis, pelvic floor abscess. Timepoint: Visit on the third day after surgery. Method of measurement: Visit and view patient records.;Length of hospital stay. Timepoint: Patients will be followed up for up to 6 weeks. Method of measurement: Visit and view patient records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Roya Faraji Darkhaneh
Rasht University of Medical Sciences
Outcome results
None listed